诺瓦瓦克斯医药

$诺瓦瓦克斯医药(NVAX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000070858-26-000073  Act: 34  Size: 110 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000093751-26-000075  Act: 34  Size: 7 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-006721  Size: 8 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, item 1.01 Accession Number: 0001104659-26-004785  Act: 34  Size: 199 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001104659-26-002725  Act: 34  Size: 3 MB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-121103  Size: 8 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-111494  Size: 8 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001398344-25-020786  Act: 34  Size: 31 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001000694-25-000048  Act: 34  Size: 323 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001000694-25-000046  Act: 34  Size: 9 MB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-105818  Act: 34  Size: 225 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-104413  Size: 7 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 1.01, 2.06, 8.01, and 9.01 Accession Number: 0001104659-25-101390  Act: 34  Size: 257 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001398344-25-019099  Act: 34  Size: 146 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-097317  Act: 34  Size: 236 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-084049  Act: 34  Size: 232 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 1.01, 2.03, 3.02, and 9.01 Accession Number: 0001104659-25-084053  Act: 34  Size: 1 MB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001104659-25-081160  Act: 34  Size: 379 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001000694-25-000031  Act: 34  Size: 311 KB 网页链接

$诺瓦瓦克斯医药(NVAX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001000694-25-000029  Act: 34  Size: 10 MB 网页链接